Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • South Carolina guideSouth Carolina Bids and Bidding Guide
  • Education RFPsEducation Bids and Bidding Guide
  • How to answer an RFQRFQ Meaning: What Is an RFQ?
More education bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›South Carolina
  4. ›Education
  5. ›Schrödinger Small Molecule Drug Discovery Software

University of South Carolina·South Carolina

Schrödinger Small Molecule Drug Discovery Software

Closes 2/27/2026$5k – $50kRequest for Quotation
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The University of South Carolina is seeking quotes from qualified suppliers to provide Schrödinger Small Molecule Drug Discovery Software. The software is intended for use in the university's research and development efforts. To obtain a quotation sheet, interested suppliers should email Donald Stewart at [email protected]. All quotes must be emailed directly to Donald Stewart by 5:00 PM ET on February 27, 2026. • The software should be suitable for small molecule drug discovery research • The supplier should provide a quotation sheet with detailed pricing and product information • The university is seeking bona fide quotes from qualified suppliers • The software will be used in a research and development setting

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

Donald Stewart(Purchasing Agent)

[email protected]

(803) 777-5253

Key dates

Opened
2/24/2026
Closes
2/27/2026

Last updated

Details

Type
Request for Quotation
Industry
Education
NAICS
511210
Solicitation №
N/A

Budget estimate

$5,000 – $50,000

The budget for this opportunity is likely to be in the range of $5,000 to $50,000, depending on the specific software and licensing requirements. This estimate is based on the assumption that the software is a specialized tool for small molecule drug discovery research and may require annual licensing fees or subscription-based pricing. The university's research and development efforts may also require additional features or support, which could impact the overall cost.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 71%

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development

Closes 6/15/2027Opened 7/7/2026

University of Texas MD Anderson Cancer Center·Texas

66% match

Discovery and Development of Small Molecules and Biologic Therapies RFP

Closes 12/9/2026Opened 10/30/2026

U.S. National Institutes of Health·United States of America

66% match

Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed)

Closes 3/5/2027Opened 9/29/2025

U.S. National Institutes of Health·United States of America

66% match

Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

Closes 12/23/2027Opened 11/22/2024

U.S. National Institutes of Health·United States of America

64% match

Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)

Closes 12/23/2027Opened 11/22/2024

U.S. Department Of Energy·Ohio

63% match

TECHNOLOGY LICENSING OPPORTUNITY: SurfGraphPro

Closes 12/5/2026Opened 6/5/2026

U.S. National Institutes of Health·United States of America

63% match

BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)

Closes 6/15/2027Opened 9/25/2024

National Aeronautics And Space Administration·United States of America

63% match

TECHNOLOGY TRANSFER OPPORTUNITY: Portable Microscope (MSC-TOPS-131)

Closes 8/10/2027Opened 8/10/2026

U.S. Department Of Energy·Ohio

63% match

TECHNOLOGY LICENSING OPPORTUNITY: Multi-Channel Atomic Magnetometer (MCAM)

Closes 12/12/2026Opened 7/17/2026

U.S. National Institutes of Health·United States of America

63% match

NIDA Avenir Program: Fundamental Mechanistic Research in Addiction Science

Closes 5/25/2027Opened 9/10/2026

U.S. Department Of Defense·Virginia

63% match

Atomically Precise Molecules (APM)

Closes 12/18/2026Opened 10/8/2026

U.S. National Institutes of Health·United States of America

63% match

Technology Development Program

Closes 2/4/2028Opened 9/16/2026

U.S. National Institutes of Health·United States of America

63% match

National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)

Closes 10/25/2027Opened 1/15/2025

U.S. National Institutes of Health·United States of America

63% match

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Closes 11/5/2027Opened 11/15/2021

U.S. National Institutes of Health·United States of America

62% match

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Closes 6/17/2027Opened 8/13/2026

U.S. Department Of Defense·Virginia

62% match

Atomically Precise Molecules (APM)

Closes 12/18/2026Opened 9/25/2026

U.S. National Science Foundation·United States of America

62% match

MPS Chemistry Research Programs (MPS Chem)

Closes 10/7/2076Opened 8/17/2026

U.S. Food and Drug Administration·United States of America

62% match

Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed

Rolling / TBD closeOpened 11/24/2023

U.S. Department Of Energy·New Mexico

62% match

SOFTWARE LICENSING OPPORTUNITY: CorrelateIQ - Correlation-Based System Intelligence

Closes 10/31/2026Opened 10/16/2026

U.S. Department Of Health And Human Services·Indiana

62% match

NOI - B2B Award entitled - Developing Red Cell-Sp

Closes 11/4/2026Opened 10/20/2026

U.S. Department Of Energy·Ohio

62% match

TECHNOLOGY LICENSING OPPORTUNITY: Maximum Length Sequence Phase Encoding for Quantum Sensor Readout

Closes 12/22/2026Opened 6/24/2026

National Aeronautics And Space Administration·United States of America

62% match

TECHNOLOGY TRANSFER OPPORTUNITY: Portable Slide Staining System for Microscopy (MSC-TOPS-132)

Closes 8/10/2027Opened 8/10/2026

U.S. Department Of Defense·New York

62% match

QUANTUM INFORMATION SCIENCES

Closes 9/30/2027Opened 4/25/2023

U.S. National Institutes of Health·United States of America

62% match

Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

Closes 8/18/2027Opened 10/1/2024

U.S. National Institutes of Health·United States of America

62% match

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Closes 3/1/2027Opened 1/8/2026